/PRNewswire/ CND Life Sciences, Inc. (www.cndlifesciences.com), an innovative medical diagnostics company pioneering the detection, visualization, and.
CND Life Sciences Adds Biopharma Veteran to Its Board prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
CND Life Sciences Partners With FFF Enterprises And NuFactor
Strategic Collaboration Educates Neurology Community About Syn-One Test™
News provided by
Share this article
Share this article
PHOENIX and TEMECULA, Calif., April 22, 2021 /PRNewswire/ CND Life Sciences, Inc., an innovative medical technology company pioneering the detection, visualization, and quantification of protein deposition in cutaneous nerve fibers, announced today its national collaboration with NuFactor
®, a specialty infusion company and subsidiary of FFF Enterprises, Inc., to educate neurologists on the availability and application of the Syn-One Test™.
The collaboration focuses on engaging neuromuscular specialists and general neurologists in the U.S. who treat patients with signs and symptoms of synucleinopathies, including Parkinson s disease, multiple system atrophy, and pure autonomic failure. For a significant percentage of patients, physicians lack objective pathological proof to help conf
CND Life Sciences to Present at Biotech Showcase Investor Conference
Poised for Growth After Successful Launching First Skin-Based Test for Parkinson s
News provided by
Share this article
PHOENIX, Jan. 8, 2021 /PRNewswire/ CND Life Sciences (
cndlifesciences.com), an innovative medical technology company pioneering the detection, visualization, and quantification of protein deposition in cutaneous nerve fibers, will participate in the 2021 virtual Biotech Showcase taking place during the 39th Annual J.P. Morgan Healthcare Conference (January 11-14, 2021). The company is capitalizing on a wave of forward momentum fueled by the first full-year of commercialization and adoption of its
for Parkinson s disease and other neurological disorders.